Gönüllü Erdem, Topçu Burcu, Öner Naci, Soysal Ahmet, Karaböcüoğlu Metin
Memorial Ataşehir Hospital, Department of Pediatrics, 34758 Istanbul, Turkey.
Memorial Ataşehir Hospital, Department of Pediatric Cardiology, 34758 Istanbul, Turkey.
Case Rep Pediatr. 2019 Sep 22;2019:4591964. doi: 10.1155/2019/4591964. eCollection 2019.
Meningococcal serogroup B vaccine 4CMenB (Bexsero) is a new four-component protein vaccine developed to prevent serogroup B infections. . We report a girl with fever and supraventricular tachycardia (SVT) 6-8 hours after the second dose of 4CMenB. SVT was unresponsive to the first dose of adenosine but terminated after the fourth dose of adenosine. During three months of follow-up, she was free of further SVT attacks. . This is the first report of ECG-proven SVT after 4CMenB vaccination. Even if fever is coexistent, SVT should be considered after persistent tachycardia and 4CMenB vaccination.
B群脑膜炎球菌疫苗4CMenB(Bexsero)是一种新的四组分蛋白疫苗,用于预防B群感染。我们报告一名女孩在接种第二剂4CMenB疫苗6至8小时后出现发热和室上性心动过速(SVT)。SVT对第一剂腺苷无反应,但在第四剂腺苷后终止。在三个月的随访期间,她未再发生SVT发作。这是4CMenB疫苗接种后经心电图证实的SVT的首例报告。即使同时存在发热,在持续心动过速和接种4CMenB疫苗后也应考虑SVT。